The most recent guidelines from the Infectious Diseases Society of America (IDSA) and its European counterpart on the choice of antimicrobials for treatment of uncomplicated urinary tract infections (UTIs) in non-pregnant women focus on the unnecessary use of fluoroquinolones to treat uropathogens that are increasingly becoming resistant to them.1 Resistance of Escherichia coli to ciprofloxacin in the US has increased from 3% in 2000 to 17.1% in 2010.2
Drugs for Urinary Tract Infections. JAMA. 2014;311(8):855–856. doi:10.1001/jama.2014.972
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.